BDNF and pancreatic adenocarcinoma: Scatter diagrams obtained by Wilcoxon rank-sum tests demonstrated that high levels of BDNF were observed in PAAD patients with the following characteristics (Figure 3(b)): aged less than 65 years (p = 0.014) and AJCC T3–T4 stage (p = 0.011).